 |
Daniel Cramer,MD, ScD |
Daniel Cramer, MD, ScD, director of the Obstetrics/Gynecology Epidemiology Center, recently received the Outstanding Investigator Award (OIA) from the National Cancer Institute for his exemplary work involving cancer research.
The award is meant to provide long-term support to investigators whose careers demonstrate excellent records of cancer research and are looking to explore potential new and unusual avenues of research. The OIA includes a seven-year grant that will allow investigators stability to continue their current research while also exploring different lines of inquiry and new cancer research techniques.
Cramer is a co-leader of the Gynecological Cancers Program, which seeks to improve methods of prevention, diagnosis and treatment of gynecologic cancers. His research focuses on the epidemiology of ovarian cancer, with the goal to develop a model to explain risk factors for the disease. Currently Cramer's research focuses on glycoprotein tumor antigens, which bind to white blood cells and trigger an immune response to tumors, and the occurrence of anti-mucin antibodies, which can limit growth in cancerous tumors. He was awarded the grant for his proposal of new assays and studies to advance understanding of mucin-immune cell interactions in ovarian cancer pathogenesis and progression.
